TABLE 8.
SUMMARY OF CLINICAL CHARACTERISTICS OF PATIENTS WITH DIABETIC PAPILLOPATHY
| PATIENT | AGE | GENDER | EYE | TYPE |
DIABETES DURATION (MONTHS) |
HYPER- TENSION |
HYPER- LIPIDEMIA |
SMOKER | ACUITY |
VISUAL FIELD |
CUP- DISC RATIO |
DISC VASCULAR DILATION |
DIABETIC RETINO- PATHY |
RESO- LUTION (MONTHS) |
OPTIC ATROPHY |
FOLLOW- UP (MONTHS) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 49 | F | OD | 2 | 48 | − | − | − | 20/20 | NL | 0.1 | − | − | 3 | 1+ | 3 |
| 2 | 46 | F | OD | 1 | 12 | + | X | X | 20/80 | BS | 0.1 | + | PDR | 5 | − | 5 |
| 3 | 16 | F | OU | 1 | 168 | − | − | − | 20/25, | CS | 0.0 0.0 | + | NPDR,CME, | 5 | − | 6 |
| 20/80 | + | NPDR | 5 | − | 6 | |||||||||||
| 4 | 48 | M | OD | 2 | 240 | + | + | + | 20/40 | CS | 0.0 | + | NPDR,CME | 3 | 1+ | 2 |
| 5 | 33 | M | OD | 1 | 260 | − | − | X | 20/80 | BS | 0.0 | − | PDR,CME | 2 | 1+ | 120 |
| 6 | 47 | F | OD | 1 | 492 | − | − | + | 20/20 | BS | 0.0 | − | PDR | 3 | − | 5 |
| 7 | 44 | F | OS | 1 | 300 | − | − | − | 20/40 | BS | 0.1 | + | NPDR | 4 | TR | 32 |
| 8 | 49 | M | OD | 2 | 120 | − | − | − | 20/40 | BS | 0.1 | − | NPDR | 12 | TR | 33 |
| 9 | 49 | M | OS | 2 | 84 | − | + | + | 20/50 | BS | 0.1 | + | NPDR | 12 | 1+ | 12 |
| 10 | 28 | F | OS | 1 | 180 | − | − | − | 20/20 | BS | 0.0 | + | NPDR | 2 | − | 4 |
| 11 | 48 | F | OU | 2 | 84 | + | + | − | 20/25 | BS | 0.1 | + | NPDR | 6 | − | 7 |
| 20/25 | BS | 0.0 | + | NPDR | 6 | − | 7 | |||||||||
| 12 | 49 | F | OD | 2 | 48 | − | − | − | 20/20 | NL | 0.1 | − | − | 6 | − | 6 |
BS, blind spot enlargement; CME, cystoid macular edema; CS, cecocentral;, NL, normal; NPDR, nonproliferative diabetic retinopathy; PDR, proliferative diabetic retinopathy; X, data not available.